Main Menu

Global Blood Therapeutics, Inc.


Rigrodsky Law, P.A. is investigating Global Blood Therapeutics, Inc. (“Global Blood”) regarding possible breaches of fiduciary duties and other violations of law related to Global Blood’s agreement to be acquired by Pfizer Inc.  Under the terms of the agreement, Global Blood’s shareholders will receive $68.50 per share.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 02/07/2023

* Indicates a required field.

Back to Page